Labiotech.eu

News and Trends 23 Feb 2017

Biosimilars set to take on Oncology after a new Market Authorization

The European Commission has approved Truxima, the world’s first biosimilar monoclonal antibody (mAb) with an oncology indication. Based in South Korea, Celltrion Healthcare is setting foot in the European oncology market with the approval of Truxima, a biosimilar to Roche’s Mabthera (rituximab). The European Commission has approved the antibody for non-Hodgkin’s lymphoma, chronic lymphocytic leukemia, rheumatoid arthritis […]

February 23, 2017 - 3 minutesmins - By Melanie De Almeida

News and Trends 23 Feb 2017

NGS Metagenomics Test could Curb Antibiotic-Resistant Infections

PathoQuest has shown its metagenomics sequencing technology can identify more pathogens in immunocompromised patients than the standard procedures, keeping antibiotic-resistant infections at bay. PathoQuest, a spin-off from the Institut Pasteur in Paris, develops next-generation sequencing (NGS) metagenomics tests. The company just announced the publication of results from a clinical trial comparing its iDTECT Blood technology […]

February 23, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 23 Feb 2017

Reach for the BioStars! Meet the Top 3 Biotech Startups from Oxford

A new round of this young startup competition is underway! What is this Oxford-based competition, and who competes? We talked to previous participants. BioStars is a flagship startups booster run by a group of PhDs, MBA and post-docs, who dedicate their spare time to enabling bio-entrepreneurs to turn their scientific ideas into actual products. Brought […]

February 23, 2017 - 5 minutesmins - By External Contributor

Apollo Therapeutics drug discovery launch

News and Trends 22 Feb 2017

UK’s Joint Venture Bridging Academia and Industry is Ready for Kick Off

Apollo Therapeutics is a UK-based joint venture bridging academia and industry to drive the translation of university research. Its first four drug discovery programmes will now be launched. Apollo Therapeutics was founded in early 2016 as a collaborative effort of the three global pharmaceutical companies, AstraZeneca, GlaxoSmithKline and Johnson & Johnson Innovation, and the world-leading UK-universities, Imperial College London, UCL and the University of […]

February 22, 2017 - 2 minutesmins - By Melanie De Almeida

News and Trends 22 Feb 2017

Roche doubles down in Fight against Antibiotic Resistance

In 2014, Discuva partnered up with Roche to develop new antibiotics against multidrug-resistant bacteria. The two companies have announced an extension of their collaboration until February 2018. The Cambridge-based company Discuva wants to address the critical need for new antibiotic drugs to treat infections from multidrug-resistant bacteria. Posing a major public health threat, antibiotic resistances cause at least 25,000 deaths per year in […]

February 22, 2017 - 2 minutesmins - By Melanie De Almeida

News and Trends 22 Feb 2017

Meet these 5 Awesome Biotechs from Barcelona at BIO Europe Spring 2017

As BIO Europe Spring 2017 approaches, we decided to take a closer look into biotechs from Barcelona, one of the hottest biotech hubs in Europe. Spring is coming and with it a new edition of BIO Europe Spring that will take place by the beach in Barcelona. The city has established itself as a hub for life sciences within […]

February 22, 2017 - 5 minutesmins - By External Contributor

Apitope Multiple Sclerosis ATX MS 1467 phase IIa 1

News and Trends 21 Feb 2017

A New Peptide Vaccine for Multiple Sclerosis Succeeds in Phase IIa

Apitope is developing therapeutic peptides to induce suppression of autoimmune responses towards self-antigens. Their recent phase IIa trial has revealed promising results for the treatment of multiple sclerosis. Multiple sclerosis (MS) is a hot topic these days. While a recent long-term study revealed the potential of hematopoietic stem cell transplantation for the treatment of MS, this treatment strategy is […]

February 21, 2017 - 3 minutesmins - By Melanie De Almeida

News and Trends 21 Feb 2017

New Immunotherapy Candidate receives FDA Fast Track Designation

Cell Medica’s Orphan Drug CMD-003 has received fast track designation by the FDA to advance immunotherapy of patients with Epstein Bar Virus (EBV)-associated malignancies. The FDA’s fast track designation has been designed to facilitate and accelerate the development of drugs which fill a major unmet medical need. It has now been granted to Cell Medica’s lead EBV immunotherapy […]

February 21, 2017 - 3 minutesmins - By Melanie De Almeida

Infographics 21 Feb 2017

Infographic: The Biggest Biotech Company in Each European Country

We had a look into European biotech and created a map with the biggest biotech companies in each country, according to their market cap. Biotech is one of the biggest employers in Europe, where companies of all sizes strive to bring the most innovative technology to the market. To illustrate the dynamic biotech ecosystem in […]

February 21, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

centauri therapeutics fundraising alphamer anti infective e1487589778369

News and Trends 20 Feb 2017

Alphamer Technology gets Seed Fundraising to Fight Antibiotic Resistance

Centauri Therapeutics has raised £1.2M in the second part of its seed round, which will be directed at bringing its first alphamer to the preclinical stage. Centauri Therapeutics, a young British biotech, is developing alphamer technology to fights infectious disease and cancer. Today, the company has announced the addition of £1.2M from existing and new investors […]

February 20, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

News and Trends 20 Feb 2017

CEVEC is Transforming Vaccine Development starting with Zika

CEVEC Pharmaceuticals recently partnered up with NewLink Genetics to use its CAP technology for the development of new vaccines against the Zika virus. We had the opportunity to ask CEVECs CSO a few questions about how their technology can transform vaccine development. CEVEC Pharmaceuticals is developing high-quality platforms for the efficient and safe production of glycosylated proteins, viral vaccines and […]

February 20, 2017 - 6 minutesmins - By External Contributor

Russ Cummings Touchstone Innovations Edited e1487839162471

Interview 20 Feb 2017

Investment CEO shares Tips for Academics on Succeeding in Business

With decades of experience, the CEO of Touchstone Innovations tells us about funding the development of academic projects into commercialized products Formerly known as Imperial Innovations, the investing arm of Imperial College in London has since morphed into Touchstone Innovations, an UK technology commercialization and investment company with the same core mission in bridging the gap […]

February 20, 2017 - 7 minutesmins - By Evelyn Warner

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Biosimilars set to take on Oncology after a new Market Authorization

NGS Metagenomics Test could Curb Antibiotic-Resistant Infections

Reach for the BioStars! Meet the Top 3 Biotech Startups from Oxford

UK’s Joint Venture Bridging Academia and Industry is Ready for Kick Off

Roche doubles down in Fight against Antibiotic Resistance

Meet these 5 Awesome Biotechs from Barcelona at BIO Europe Spring 2017

A New Peptide Vaccine for Multiple Sclerosis Succeeds in Phase IIa

New Immunotherapy Candidate receives FDA Fast Track Designation

Infographic: The Biggest Biotech Company in Each European Country

Alphamer Technology gets Seed Fundraising to Fight Antibiotic Resistance

CEVEC is Transforming Vaccine Development starting with Zika

Investment CEO shares Tips for Academics on Succeeding in Business

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!